close read more

Launch of IFPMA’s Global Health Progress platform


Launch of IFPMA’s Global Health Progress platform

Servier partners with IFPMA to launch a global database on health care access projects

Together with the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Servier is pleased to announce the official launch of the Global Health Progress platform on the October 25th World Health Summit. This platform highlights and classifies collaborations between the innovative pharmaceutical industry and multi-sector partners which work towards increasing access to healthcare in low and middle-income countries. It also shares best practices to support continual learning and expand the reach and impact of access programmes.

With over 200 partnerships listed, the platform demonstrates the collective effort of the pharmaceutical companies belonging to IFPMA to support the achievement of the United Nations’ Sustainable Development Goals (SDG) by 2030 and improve health around the world.

Complex health and wellbeing issues remain – from poverty and inequality to climate change. Many countries are faced with a double burden of disease – as they continue to tackle infectious disease challenges, they also battle with an increasing prevalence of non-communicable diseases (NCDs) – which present new issues in implementing effective and sustainable solutions for health. The innovative biopharmaceutical industry recognizes the need for new approaches to reach the 2030 deadline.

The new platform features two of Servier’s access programmes, which were developed between Mécénat Servier and respectively La Chaîne de l’Espoir in Senegal and Helen Keller International in Vietnam. These programmes highlight Servier’s commitment to work alongside various partners to serve patient needs. You can access the Global Health Progress platform here, and Servier’s page here.

For any additional information, please contact Harold Cottin (for IFPMA): harold.cottin@servier.com and Corinne Massin (for Mécénat): corinne.massin@servier.com

Last news

Meeting the challenge of adherence: a Servier study presented at the ESH 2022 Annual Meeting!
Appointment of Angelo Paci, Oncology & Immuno-Oncology Program Leader
Patient associations’ perception of pharmaceutical companies: Servier is making progress!